$184.25
2.31% today
NYSE, Aug 12, 04:44 pm CET

IQVIA Stock price

$180.09
+17.29 10.62% 1M
-20.80 10.35% 6M
-16.42 8.36% YTD
-51.37 22.19% 1Y
-61.91 25.58% 3Y
+20.78 13.04% 5Y
+104.71 138.91% 10Y
+137.98 327.67% 20Y
NYSE, Closing price Mon, Aug 11 2025
+0.23 0.13%

Key metrics

Basic
Market capitalization
$30.6b
Enterprise Value
$43.9b
Net debt
$13.3b
Cash
$2.2b
Shares outstanding
170.0m
Valuation (TTM | estimate)
P/E
25.2 | 15.1
P/S
2.0 | 1.9
EV/Sales
2.8 | 2.7
EV/FCF
21.8
P/B
5.3
Financial Health
Equity Ratio
22.6%
Return on Equity
22.6%
ROCE
10.8%
ROIC
9.1%
Debt/Equity
2.7
Financials (TTM | estimate)
Revenue
$15.7b | $16.3b
EBITDA
$3.4b | $3.8b
EBIT
$2.3b | $3.1b
Net Income
$1.2b | $2.0b
Free Cash Flow
$2.0b
Growth (TTM | estimate)
Revenue
3.6% | 6.0%
EBITDA
4.3% | 12.8%
EBIT
7.9% | 36.2%
Net Income
-13.1% | 48.0%
Free Cash Flow
10.0%
Margin (TTM | estimate)
Gross
34.3%
EBITDA
21.6% | 23.4%
EBIT
14.4%
Net
7.9% | 12.4%
Free Cash Flow
12.8%
More
EPS
$7.1
FCF per Share
$11.8
Short interest
6.2%
Employees
88k
Rev per Employee
$180.0k
Show more

Is IQVIA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

IQVIA Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a IQVIA forecast:

20x Buy
69%
9x Hold
31%

Analyst Opinions

29 Analysts have issued a IQVIA forecast:

Buy
69%
Hold
31%

Financial data from IQVIA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
15,700 15,700
4% 4%
100%
- Direct Costs 10,323 10,323
5% 5%
66%
5,377 5,377
1% 1%
34%
- Selling and Administrative Expenses 1,992 1,992
4% 4%
13%
- Research and Development Expense - -
-
-
3,385 3,385
4% 4%
22%
- Depreciation and Amortization 1,122 1,122
2% 2%
7%
EBIT (Operating Income) EBIT 2,263 2,263
8% 8%
14%
Net Profit 1,237 1,237
13% 13%
8%

In millions USD.

Don't miss a Thing! We will send you all news about IQVIA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IQVIA Stock News

Positive
Seeking Alpha
21 days ago
IQVIA Holdings Inc.'s Q1 results highlighted strong profitability, robust TAS growth, and a healthy backlog, reaffirming its leadership in healthcare data and analytics. Despite sector headwinds, I remained bullish on IQVIA and expected Q2 to meet or beat estimates, viewing analyst forecasts as a conservative floor. The company did not disappoint. Key risks include delayed clinical trials, shri...
Neutral
Seeking Alpha
21 days ago
IQVIA Holdings Inc. (NYSE:IQV ) Q2 2025 Earnings Conference Call July 22, 2025 9:00 AM ET Company Participants Ari Bousbib - CEO & Chairman Kerri Joseph - Corporate Participant SVP of Investment Relation & Treasury - Corporate Participant Ronald E. Bruehlman - Executive VP & CFO Conference Call Participants Ann Kathleen Hynes - Mizuho Securities USA LLC, Research Division Christine Rains - Will...
Positive
Investors Business Daily
21 days ago
Iqvia stock surged Tuesday after the clinical resource organization widely beat most second-quarter metrics, though trimmed its outlook.
More IQVIA News

Company Profile

Provides biopharmaceutical development services and commercial outsourcing services

Head office United States
CEO Ari Bousbib
Employees 88,000
Founded 1950
Website ir.iqvia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today